Difference between revisions of "S-100"

Jump to navigation Jump to search
1,373 bytes added ,  19:29, 11 February 2021
rename
(rename)
 
(9 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{ Infobox immunostain
| Name      = {{PAGENAME}}
| Image      = Mammary_analogue_secretory_carcinoma_(S100immunohistochemstry,_low_power).jpg
| Width      =
| Caption    = S-100 staining in a [[secretory carcinoma of the salivary gland]].
| Abbrev    =
| Synonyms  =
| Similar    =
| Clones    =     
| Use        = [[malignant melanoma]], assess [[perineural invasion]], undifferentiated malignancy
| Subspecial = 
| Pattern    = nucleus and cytoplasm
| Positive  = benign: nerves, adipose tissue; tumour/other: [[granular cell tumour]], [[Rosai-Dorfman disease]]; malignant: [[malignant melanoma]], [[clear cell sarcoma]], [[malignant peripheral nerve sheath tumour]]
| Negative  =
| Other      =
}}
'''S-100''', also '''S100''', is a commonly used [[immunostain]].  It marks nerves.
'''S-100''', also '''S100''', is a commonly used [[immunostain]].  It marks nerves.


Line 4: Line 20:
==Positive==
==Positive==
*Nerves.
*Nerves.
*[[Schwannoma]].
*Mature adipose tissue.
*Mature adipose tissue.
*Interdigitating dendritic cells.<ref name=pmid19466261>{{Cite journal  | last1 = Mesquita | first1 = RA. | last2 = de Araújo | first2 = VC. | last3 = Paes | first3 = RA. | last4 = Nunes | first4 = FD. | last5 = de Souza | first5 = SC. | title = Immunohistochemical analysis for CD21, CD35, Caldesmon and S100 protein on dendritic cells types in oral lymphomas. | journal = J Appl Oral Sci | volume = 17 | issue = 3 | pages = 248-53 | month =  | year =  | doi =  | PMID = 19466261 }}
*Interdigitating dendritic cells.<ref name=pmid19466261>{{Cite journal  | last1 = Mesquita | first1 = RA. | last2 = de Araújo | first2 = VC. | last3 = Paes | first3 = RA. | last4 = Nunes | first4 = FD. | last5 = de Souza | first5 = SC. | title = Immunohistochemical analysis for CD21, CD35, Caldesmon and S100 protein on dendritic cells types in oral lymphomas. | journal = J Appl Oral Sci | volume = 17 | issue = 3 | pages = 248-53 | month =  | year =  | doi =  | PMID = 19466261 }}
Line 9: Line 26:
*[[Langerhans cell histiocytosis]].
*[[Langerhans cell histiocytosis]].
*[[Rosai-Dorfman disease]].
*[[Rosai-Dorfman disease]].
*[[Schwannoma]].
*[[Chordoma]] - also keratin positive ([[AE1/AE3]], [[CK19]], [[CAM5.2]]).<ref name=pmid24296480>{{Cite journal  | last1 = Shen | first1 = J. | last2 = Shi | first2 = Q. | last3 = Lu | first3 = J. | last4 = Wang | first4 = DL. | last5 = Zou | first5 = TM. | last6 = Yang | first6 = HL. | last7 = Zhu | first7 = GQ. | title = Histological study of chordoma origin from fetal notochordal cell rests. | journal = Spine (Phila Pa 1976) | volume = 38 | issue = 25 | pages = 2165-70 | month = Dec | year = 2013 | doi = 10.1097/BRS.0000000000000010 | PMID = 24296480 }}</ref>
*[[Granular cell tumour]].
*[[Nodal nevus]].


===Malignant tumours===
===Malignant tumours===
Line 15: Line 34:
*[[Malignant peripheral nerve sheath tumour]].
*[[Malignant peripheral nerve sheath tumour]].
*[[Clear cell sarcoma]].
*[[Clear cell sarcoma]].
*[[Mammary analogue secretory carcinoma]].


==See also==
==See also==
48,466

edits

Navigation menu